Analystreport

Pacira Pharmaceuticals Inc (NASDAQ: PCRX) had its price target lowered by analysts at HC Wainwright to $45.00. They now have a "buy" rating on the stock.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com